![Shahzad Hassan Profile](https://pbs.twimg.com/profile_images/1503750154037440522/1dHKR5lB_x96.jpg)
Shahzad Hassan
@ShahzadHTarar
Followers
203
Following
862
Statuses
44
MD, MSCR @BUMedicine, @MUSCflorence, Attending Physician @The_BMC, @newtonwellesley, Post Doc research fellow BWH
Boston, MA
Joined January 2010
RT @jllbmd: Go check our latest paper in #JACCHF led by the amazing @ShahzadHTarar @Zaralatif5 & @haiderwarraich 👏🏽👏🏽👏🏽
0
7
0
RT @haiderwarraich: Lots we dont know about heart failure with preserved ejection fraction but one thing we do: palliative care would be im…
0
10
0
RT @AJBloodMD: Humbled to receive the invitation to give CV grand rounds at my home institution, @BrighamWomens - a credit to my mentors &…
0
5
0
RT @ZaralatifMD: Excited to present our work on trends of palliative care utilization in patients with 🫀HFpEF. While there’s an ⬆️ trend in…
0
4
0
In-hospital palliative care utilization rates in acute HFpEF are rising but remain lower than other acute HF phenotypes. Our work presented at #ACC24 by @ZaralatifMD, under the worthy mentorship of @haiderwarraich. @ACCinTouch @AJBloodMD
Palliative care is underused in heart failure, but even more so in patients with preserved ejection fraction which largely affects older adults with multiple comorbidities and poor prognosis. 👇 happening now at #ACC24 led by @ZaralatifMD & @ShahzadHTarar !
0
2
4
RT @CircAHA: #CircACC24 #SimPub Diabetes Remote Intervention to improve SGLT2i and GLP-1 RA utilization for patients with T2D and high CV o…
0
4
0
RT @OzanUnluMD: #ACC24 #LBCT @AJBloodMD presenting the results of DRIVE study that was run by our Accelerator for Clinical Transformation r…
0
8
0
Really excited about this, see you all in main tent #ACC24
Join me in the Main Tent for the late breaking clinical trials starting in a few minutes to hear the results of the DRIVE trial along with exciting new science! #ACC24 @cpcannon @DeborahWexler @BScirica
0
0
3
If you are attending #ACC24, please stop by at poster 112 where we share the data on long term benefits of intensive remote hypertension management program. 90% participants maintained their mean SBP <140, up to 42 months post-enrollment
1
2
15
RT @AJBloodMD: Honored to present a Late Breaking Clinical Trial at #ACC24 - The Diabetes Remote Intervention to Improve Use of Evidence-ba…
0
5
0
RT @OzanUnluMD: Thrilled to return to Philly for #AHA2023! Cannot wait to present our latest work, support my colleagues from Accelerator f…
0
4
0
RT @AJBloodMD: Made it to Philadelphia and excited for #AHA23 - some great trials being presented and excited to partake in quite a few mod…
0
4
0
Excited to be back in Philly to attend #AHA23. Look forward to presenting our work, learning updates in 🫀 medicine and connecting with mentors, colleagues and friend. @AHAScience @AHA_Research
0
2
7
RT @SeeFisch: Dear Applicants You will not be penalized for not “signaling” my program Safe it for insecure program directors who need tha…
0
50
0
@VeroWirtz @BUSPH Congratulations, i took your global health course, it was really an academically enriching experience. Thank you for your mentorship and willingness to always help.
0
0
1